Skip to main content
Top
Gepubliceerd in: Quality of Life Research 4/2014

01-05-2014 | Review

Meta-analysis shows clinically relevant and long-lasting deterioration in health-related quality of life after esophageal cancer surgery

Auteurs: M. Jacobs, R. C. Macefield, R. G. Elbers, K. Sitnikova, I. J. Korfage, E. M. A. Smets, I. Henselmans, M. I. van Berge Henegouwen, J. C. J. M. de Haes, J. M. Blazeby, M. A. G. Sprangers

Gepubliceerd in: Quality of Life Research | Uitgave 4/2014

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Abstract

Purpose

The purpose of the study is to (1) estimate the direction, clinical relevance, and duration of health-related quality of life (HRQL) change in the first year following esophageal cancer surgery and (2) to assess the robustness of the estimates by subgroup and sensitivity analyses, and an exploration of publication bias.

Methods

A systematic literature search in MEDLINE, EMBASE, CINAHL, PsychINFO, and CENTRAL to identify randomized and non-randomized studies was performed. We compared the baseline HRQL data with 3-, 6-, 9-, or 12-month follow-ups to estimate the magnitude and duration of HRQL change. These estimates were then classified as trivial, small, medium, or large. Primary outcomes were role functioning, eating, and fatigue. Secondary outcomes were physical and social functioning, dysphagia, pain, and coughing problems. We conducted subgroup analysis for open surgery, open surgery preceded by neo-adjuvant therapy, and minimally invasive surgery. Sensitivity analyses assessed the influence of study design, transformation/imputation of the data, and HRQL questionnaire used.

Results

We included data from 15 studies to estimate the change in 28 HRQL outcomes after esophageal cancer surgery. The main analysis showed that patients’ social functioning deteriorated. Symptoms of fatigue, pain, and coughing problems increased. These changes lasted for 9–12 months, although some symptoms persisted beyond the first year after surgery. For many other HRQL outcomes, estimates were only robust after subgroup or sensitivity analyses (e.g., role and physical functioning), or remained too heterogeneous to interpret (e.g., eating and dysphagia).

Conclusions

Patients will experience a clinically relevant and long-lasting deterioration in HRQL after esophageal cancer surgery. However, for many HRQL outcomes, more and better quality evidence is needed.
Bijlagen
Alleen toegankelijk voor geautoriseerde gebruikers
Voetnoten
1
A large change indicates a clear clinical relevance. A medium change indicates a clinical relevance, but to a lesser extent. A small change indicates a subtle but nevertheless clinically relevant effect. A trivial change indicates either a change of unlikely clinical relevance, or no change.
 
2
QLQ-C30: global quality of life, physical functioning, role functioning, cognitive functioning, emotional functioning, social functioning, fatigue, nausea and vomiting, insomnia, constipation, pain, diarrhea, appetite loss, dyspnoea, and financial difficulties. QLQ-OES18: dysphagia, eating, reflux, swallowing saliva, choking when swallowing, speech, taste problems, and coughing problems. QLQ-OES24: deglutition, alopecia, trouble talking, emotional problems/anxiety. SF-36: role physical, role emotional, bodily pain, mental health, and vitality. FACT-E: physical well-being, functional well-being, social/family well-being, emotional well-being, oesophageal cancer subscale, fact-E total, and fact-G total. a-RSCL: psychological symptoms, physical symptoms, and activity level. MOS-SF-20: health perceptions, energy, and bodily pain.
 
3
QLQ-C30: global quality of life, physical functioning, role functioning, cognitive functioning, emotional functioning, social functioning, fatigue, nausea and vomiting, insomnia, constipation, pain, diarrhea, appetite loss, dyspnoea, and financial difficulties. QLQ-OES18: dysphagia, eating, reflux, pain, swallowing saliva, choking when swallowing, speech problems, taste problems, and coughing problems. QLQ-OES24: deglutition. SF-36: role functioning and social functioning. FACT-E: fact-E. A-RSCL: global quality of life. MOS-SF-20: physical functioning, role functioning, and social functioning.
 
Literatuur
1.
go back to reference Gebski, V., Burmeister, B., Smithers, B. M., Foo, K., Zalcberg, J., & Simes, J. (2007). Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: A meta-analysis. The Lancet Oncology, 8(3), 226–234.PubMedCrossRef Gebski, V., Burmeister, B., Smithers, B. M., Foo, K., Zalcberg, J., & Simes, J. (2007). Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: A meta-analysis. The Lancet Oncology, 8(3), 226–234.PubMedCrossRef
2.
go back to reference Rutegard, M., Charonis, K., Lu, Y., Lagergren, P., Lagergren, J., & Rouvelas, I. (2012). Population-based esophageal cancer survival after resection without neoadjuvant therapy: An update. Surgery, 152(2), 903–910.PubMedCrossRef Rutegard, M., Charonis, K., Lu, Y., Lagergren, P., Lagergren, J., & Rouvelas, I. (2012). Population-based esophageal cancer survival after resection without neoadjuvant therapy: An update. Surgery, 152(2), 903–910.PubMedCrossRef
3.
go back to reference Van, H. P., Hulshof, M. C., van Lanschot, J. J., Steyerberg, E. W., van Berge Henegouwen, M. I., Wijnhoven, B. P., et al. (2012). Preoperative chemoradiotherapy for esophageal or junctional cancer. New England Journal of Medicine, 366(22), 2074–2084.CrossRef Van, H. P., Hulshof, M. C., van Lanschot, J. J., Steyerberg, E. W., van Berge Henegouwen, M. I., Wijnhoven, B. P., et al. (2012). Preoperative chemoradiotherapy for esophageal or junctional cancer. New England Journal of Medicine, 366(22), 2074–2084.CrossRef
4.
go back to reference Djarv, T., & Lagergren, P. (2012). Quality of life after esophagectomy for cancer. Expert Review of Gastroenterology & Hepatology, 6(1), 115–122.CrossRef Djarv, T., & Lagergren, P. (2012). Quality of life after esophagectomy for cancer. Expert Review of Gastroenterology & Hepatology, 6(1), 115–122.CrossRef
5.
go back to reference Trask, P. C., Hsu, M. A., & McQuellon, R. (2009). Other paradigms: Health-related quality of life as a measure in cancer treatment: its importance and relevance. Cancer Journal, 15(5), 435–440.CrossRef Trask, P. C., Hsu, M. A., & McQuellon, R. (2009). Other paradigms: Health-related quality of life as a measure in cancer treatment: its importance and relevance. Cancer Journal, 15(5), 435–440.CrossRef
6.
go back to reference Henselmans, I., Jacobs, M., van Berge Henegouwen, M. I., de Haes, H. C., Sprangers, M. A., & Smets, E. M. (2012). Postoperative information needs and communication barriers of esophageal cancer patients. Patient Education and Counseling, 88(1), 138–146.PubMedCrossRef Henselmans, I., Jacobs, M., van Berge Henegouwen, M. I., de Haes, H. C., Sprangers, M. A., & Smets, E. M. (2012). Postoperative information needs and communication barriers of esophageal cancer patients. Patient Education and Counseling, 88(1), 138–146.PubMedCrossRef
7.
go back to reference Higgins J. P. T., & Green, S. (Eds.). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org. Accessed August 27, 2012. Higgins J. P. T., & Green, S. (Eds.). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.​cochrane-handbook.​org. Accessed August 27, 2012.
8.
go back to reference Guyatt, G. H., Oxman, A. D., Vist, G., Kunz, R., Brozek, J., Alonso-Coello, P., et al. (2011). GRADE guidelines: 4. Rating the quality of evidence–study limitations (risk of bias). Journal of Clinical Epidemiology, 64(4), 407–415.PubMedCrossRef Guyatt, G. H., Oxman, A. D., Vist, G., Kunz, R., Brozek, J., Alonso-Coello, P., et al. (2011). GRADE guidelines: 4. Rating the quality of evidence–study limitations (risk of bias). Journal of Clinical Epidemiology, 64(4), 407–415.PubMedCrossRef
9.
go back to reference Whistance, R. N., & Blazeby, J. M. (2011). Systematic review: Quality of life after treatment for upper gastrointestinal cancer. Current Opinion in Supportive and Palliative Care, 5(1), 37–46.PubMedCrossRef Whistance, R. N., & Blazeby, J. M. (2011). Systematic review: Quality of life after treatment for upper gastrointestinal cancer. Current Opinion in Supportive and Palliative Care, 5(1), 37–46.PubMedCrossRef
10.
go back to reference Conroy, T., Marchal, F., & Blazeby, J. M. (2006). Quality of life in patients with oesophageal and gastric cancer: An overview. Oncology, 70(6), 391–402.PubMedCrossRef Conroy, T., Marchal, F., & Blazeby, J. M. (2006). Quality of life in patients with oesophageal and gastric cancer: An overview. Oncology, 70(6), 391–402.PubMedCrossRef
11.
go back to reference Parameswaran, R., McNair, A., Avery, K. N., Berrisford, R. G., Wajed, S. A., Sprangers, M. A., et al. (2008). The role of health-related quality of life outcomes in clinical decision making in surgery for esophageal cancer: A systematic review. Annals of Surgical Oncology, 15(9), 2372–2379.PubMedCrossRef Parameswaran, R., McNair, A., Avery, K. N., Berrisford, R. G., Wajed, S. A., Sprangers, M. A., et al. (2008). The role of health-related quality of life outcomes in clinical decision making in surgery for esophageal cancer: A systematic review. Annals of Surgical Oncology, 15(9), 2372–2379.PubMedCrossRef
12.
go back to reference Sanghera, S. S., Nurkin, S. J., & Demmy, T. L. (2012). Quality of life after an esophagectomy. Surgical Clinics of North America, 92(5), 1315–1335.PubMedCrossRef Sanghera, S. S., Nurkin, S. J., & Demmy, T. L. (2012). Quality of life after an esophagectomy. Surgical Clinics of North America, 92(5), 1315–1335.PubMedCrossRef
13.
go back to reference Fernandez, F. G., & Meyers, B. F. (2004). Quality of life after esophagectomy. Seminars in Thoracic and Cardiovascular Surgery, 16(2), 152–159.PubMedCrossRef Fernandez, F. G., & Meyers, B. F. (2004). Quality of life after esophagectomy. Seminars in Thoracic and Cardiovascular Surgery, 16(2), 152–159.PubMedCrossRef
14.
go back to reference Jacobs, M., Macefield, R. C., Blazeby, J. M., Korfage, I. J., van Berge Henegouwen, M. I., de Haes, H. C., et al. (2012). Systematic review reveals limitations of studies evaluating health-related quality of life after potentially curative treatment for esophageal cancer. Quality of Life Research,. doi:10.1007/s11136-012-0290-8. Jacobs, M., Macefield, R. C., Blazeby, J. M., Korfage, I. J., van Berge Henegouwen, M. I., de Haes, H. C., et al. (2012). Systematic review reveals limitations of studies evaluating health-related quality of life after potentially curative treatment for esophageal cancer. Quality of Life Research,. doi:10.​1007/​s11136-012-0290-8.
15.
go back to reference Borenstein, M., Hedges, L. V., Higgins, J. P., & Rothstein, H. R. (2009). Introduction to meta-analysis. Chichester: Wiley.CrossRef Borenstein, M., Hedges, L. V., Higgins, J. P., & Rothstein, H. R. (2009). Introduction to meta-analysis. Chichester: Wiley.CrossRef
16.
go back to reference Scarpa, M., Valente, S., Alfieri, R., Cagol, M., Diamantis, G., Ancona, E., et al. (2011). Systematic review of health-related quality of life after esophagectomy for esophageal cancer. World Journal of Gastroenterology, 17(42), 4660–4674.PubMedCentralPubMedCrossRef Scarpa, M., Valente, S., Alfieri, R., Cagol, M., Diamantis, G., Ancona, E., et al. (2011). Systematic review of health-related quality of life after esophagectomy for esophageal cancer. World Journal of Gastroenterology, 17(42), 4660–4674.PubMedCentralPubMedCrossRef
17.
go back to reference Maringwa, J. T., Quinten, C., King, M., Ringash, J., Osoba, D., Coens, C., et al. (2011). Minimal important differences for interpreting health-related quality of life scores from the EORTC QLQ-C30 in lung cancer patients participating in randomized controlled trials. Supportive Care in Cancer, 19(11), 1753–1760.PubMedCrossRef Maringwa, J. T., Quinten, C., King, M., Ringash, J., Osoba, D., Coens, C., et al. (2011). Minimal important differences for interpreting health-related quality of life scores from the EORTC QLQ-C30 in lung cancer patients participating in randomized controlled trials. Supportive Care in Cancer, 19(11), 1753–1760.PubMedCrossRef
18.
go back to reference Shrier, I., Boivin, J. F., Steele, R. J., Platt, R. W., Furlan, A., Kakuma, R., et al. (2007). Should meta-analyses of interventions include observational studies in addition to randomized controlled trials? A critical examination of underlying principles. American Journal of Epidemiology, 166(10), 1203–1209.PubMedCrossRef Shrier, I., Boivin, J. F., Steele, R. J., Platt, R. W., Furlan, A., Kakuma, R., et al. (2007). Should meta-analyses of interventions include observational studies in addition to randomized controlled trials? A critical examination of underlying principles. American Journal of Epidemiology, 166(10), 1203–1209.PubMedCrossRef
19.
go back to reference Ioannidis, J. P., Patsopoulos, N. A., & Rothstein, H. R. (2008). Reasons or excuses for avoiding meta-analysis in forest plots. British Medical Journal, 336(7658), 1413–1415.PubMedCentralPubMedCrossRef Ioannidis, J. P., Patsopoulos, N. A., & Rothstein, H. R. (2008). Reasons or excuses for avoiding meta-analysis in forest plots. British Medical Journal, 336(7658), 1413–1415.PubMedCentralPubMedCrossRef
20.
go back to reference Vandenbroucke, J. P. (2011). Why do the results of randomised and observational studies differ? British Medical Journal, 343, d7020.PubMedCrossRef Vandenbroucke, J. P. (2011). Why do the results of randomised and observational studies differ? British Medical Journal, 343, d7020.PubMedCrossRef
21.
go back to reference Avery, K. N., Metcalfe, C., Barham, C. P., Alderson, D., Falk, S. J., & Blazeby, J. M. (2007). Quality of life during potentially curative treatment for locally advanced oesophageal cancer. British Journal of Surgery, 94(11), 1369–1376.PubMedCrossRef Avery, K. N., Metcalfe, C., Barham, C. P., Alderson, D., Falk, S. J., & Blazeby, J. M. (2007). Quality of life during potentially curative treatment for locally advanced oesophageal cancer. British Journal of Surgery, 94(11), 1369–1376.PubMedCrossRef
22.
go back to reference Howick, J., Chalmers, I., Glasziou, P., Greenhalgh, T., Heneghan, C., Liberati, A. et al. (2011). Explanation of the 2011 Oxford centre for evidence-based medicine (OCEBM) levels of evidence (Background Document). Oxford centre for evidence-based medicine. http://www.cebm.net/index.aspx?o=5653. Accessed 27 August 2012. Howick, J., Chalmers, I., Glasziou, P., Greenhalgh, T., Heneghan, C., Liberati, A. et al. (2011). Explanation of the 2011 Oxford centre for evidence-based medicine (OCEBM) levels of evidence (Background Document). Oxford centre for evidence-based medicine. http://​www.​cebm.​net/​index.​aspx?​o=​5653. Accessed 27 August 2012.
23.
go back to reference Efficace, F., Bottomley, A., Osoba, D., Gotay, C., Flechtner, H., D’haese, S., et al. (2003). Beyond the development of health-related quality-of-life (HRQOL) measures: A checklist for evaluating HRQOL outcomes in cancer clinical trials–does HRQOL evaluation in prostate cancer research inform clinical decision making? Journal of Clinical Oncology, 21, 3502–3511.PubMedCrossRef Efficace, F., Bottomley, A., Osoba, D., Gotay, C., Flechtner, H., D’haese, S., et al. (2003). Beyond the development of health-related quality-of-life (HRQOL) measures: A checklist for evaluating HRQOL outcomes in cancer clinical trials–does HRQOL evaluation in prostate cancer research inform clinical decision making? Journal of Clinical Oncology, 21, 3502–3511.PubMedCrossRef
24.
go back to reference Blazeby, J. M., Conroy, T., Hammerlid, E., Fayers, P., Sezer, O., Koller, M., et al. (2003). Clinical and psychometric validation of an EORTC questionnaire module, the EORTC QLQ-OES18, to assess quality of life in patients with oesophageal cancer. European Journal of Cancer, 39(10), 1384–1394.PubMedCrossRef Blazeby, J. M., Conroy, T., Hammerlid, E., Fayers, P., Sezer, O., Koller, M., et al. (2003). Clinical and psychometric validation of an EORTC questionnaire module, the EORTC QLQ-OES18, to assess quality of life in patients with oesophageal cancer. European Journal of Cancer, 39(10), 1384–1394.PubMedCrossRef
25.
go back to reference Blazeby, J. M., Alderson, D., Winstone, K., Steyn, R., Hammerlid, E., Arraras, J., et al. (1996). Development of an EORTC questionnaire module to be used in quality of life assessment for patients with oesophageal cancer. The EORTC Quality of Life Study Group. European Journal of Cancer, 32(11), 1912–1917.CrossRef Blazeby, J. M., Alderson, D., Winstone, K., Steyn, R., Hammerlid, E., Arraras, J., et al. (1996). Development of an EORTC questionnaire module to be used in quality of life assessment for patients with oesophageal cancer. The EORTC Quality of Life Study Group. European Journal of Cancer, 32(11), 1912–1917.CrossRef
26.
go back to reference DerSimonian, R., & Laird, N. (1986). Meta-analysis in clinical trials. Controlled Clinical Trials, 7(3), 177–188.PubMedCrossRef DerSimonian, R., & Laird, N. (1986). Meta-analysis in clinical trials. Controlled Clinical Trials, 7(3), 177–188.PubMedCrossRef
27.
go back to reference Riley, R. D., Higgins, J. P., & Deeks, J. J. (2011). Interpretation of random effects meta-analyses. British Medical Journal, 342, d549.PubMedCrossRef Riley, R. D., Higgins, J. P., & Deeks, J. J. (2011). Interpretation of random effects meta-analyses. British Medical Journal, 342, d549.PubMedCrossRef
28.
go back to reference Higgins, J. P., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003). Measuring inconsistency in meta-analyses. British Medical Journal, 327(7414), 557–560.PubMedCentralPubMedCrossRef Higgins, J. P., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003). Measuring inconsistency in meta-analyses. British Medical Journal, 327(7414), 557–560.PubMedCentralPubMedCrossRef
29.
go back to reference Higgins, J. P., & Thompson, S. G. (2002). Quantifying heterogeneity in a meta-analysis. Statistics in Medicine, 21(11), 1539–1558.PubMedCrossRef Higgins, J. P., & Thompson, S. G. (2002). Quantifying heterogeneity in a meta-analysis. Statistics in Medicine, 21(11), 1539–1558.PubMedCrossRef
30.
go back to reference Ioannidis, J. P., Patsopoulos, N. A., & Evangelou, E. (2007). Uncertainty in heterogeneity estimates in meta-analyses. British Medical Journal, 335(7626), 914–916.PubMedCentralPubMedCrossRef Ioannidis, J. P., Patsopoulos, N. A., & Evangelou, E. (2007). Uncertainty in heterogeneity estimates in meta-analyses. British Medical Journal, 335(7626), 914–916.PubMedCentralPubMedCrossRef
31.
go back to reference Cocks, K., King, M. T., Velikova, G., de, C. G., Jr., Martyn St-James, M., & Fayers, P. M. et al. (2012). Evidence-based guidelines for interpreting change scores for the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30. European Journal of Cancer, 48(11), 1713–1721. Cocks, K., King, M. T., Velikova, G., de, C. G., Jr., Martyn St-James, M., & Fayers, P. M. et al. (2012). Evidence-based guidelines for interpreting change scores for the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30. European Journal of Cancer, 48(11), 1713–1721.
32.
go back to reference Osoba, D., Rodrigues, G., Myles, J., Zee, B., & Pater, J. (1998). Interpreting the significance of changes in health-related quality-of-life scores. Journal of Clinical Oncology, 16(1), 139–144.PubMed Osoba, D., Rodrigues, G., Myles, J., Zee, B., & Pater, J. (1998). Interpreting the significance of changes in health-related quality-of-life scores. Journal of Clinical Oncology, 16(1), 139–144.PubMed
33.
go back to reference Cohen, J. (1988). Statistical power analysis in the behavioral sciences (2nd ed.). Hillsdale, NJ: Lawrence Erlbaum Associates Inc. Cohen, J. (1988). Statistical power analysis in the behavioral sciences (2nd ed.). Hillsdale, NJ: Lawrence Erlbaum Associates Inc.
34.
go back to reference Boshier, P. R., Anderson, O., & Hanna, G. B. (2011). Transthoracic versus transhiatal esophagectomy for the treatment of esophagogastric cancer: A meta-analysis. Annals of Surgery, 254(6), 894–906.PubMedCrossRef Boshier, P. R., Anderson, O., & Hanna, G. B. (2011). Transthoracic versus transhiatal esophagectomy for the treatment of esophagogastric cancer: A meta-analysis. Annals of Surgery, 254(6), 894–906.PubMedCrossRef
35.
go back to reference Hulscher, J. B., van Sandick, J. W., de Boer, A. G., Wijnhoven, B. P., Tijssen, J. G., Fockens, P., et al. (2002). Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. New England Journal of Medicine, 347(21), 1662–1669.PubMedCrossRef Hulscher, J. B., van Sandick, J. W., de Boer, A. G., Wijnhoven, B. P., Tijssen, J. G., Fockens, P., et al. (2002). Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. New England Journal of Medicine, 347(21), 1662–1669.PubMedCrossRef
36.
go back to reference Chang, A. C., Ji, H., Birkmeyer, N. J., Orringer, M. B., & Birkmeyer, J. D. (2008). Outcomes after transhiatal and transthoracic esophagectomy for cancer. Annals of Thoracic Surgery, 85(2), 424–429.PubMedCrossRef Chang, A. C., Ji, H., Birkmeyer, N. J., Orringer, M. B., & Birkmeyer, J. D. (2008). Outcomes after transhiatal and transthoracic esophagectomy for cancer. Annals of Thoracic Surgery, 85(2), 424–429.PubMedCrossRef
37.
go back to reference Rutegard, M., Lagergren, J., Rouvelas, I., Lindblad, M., Blazeby, J. M., & Lagergren, P. (2008). Population-based study of surgical factors in relation to health-related quality of life after oesophageal cancer resection. British Journal of Surgery, 95(5), 592–601.PubMedCrossRef Rutegard, M., Lagergren, J., Rouvelas, I., Lindblad, M., Blazeby, J. M., & Lagergren, P. (2008). Population-based study of surgical factors in relation to health-related quality of life after oesophageal cancer resection. British Journal of Surgery, 95(5), 592–601.PubMedCrossRef
38.
go back to reference Yang, K., Chen, H. N., Chen, X. Z., Lu, Q. C., Pan, L., Liu, J., et al. (2012). Transthoracic resection versus non-transthoracic resection for gastroesophageal junction cancer: A meta-analysis. PLoS ONE, 7(6), e37698.PubMedCentralPubMedCrossRef Yang, K., Chen, H. N., Chen, X. Z., Lu, Q. C., Pan, L., Liu, J., et al. (2012). Transthoracic resection versus non-transthoracic resection for gastroesophageal junction cancer: A meta-analysis. PLoS ONE, 7(6), e37698.PubMedCentralPubMedCrossRef
39.
go back to reference Sjoquist, K. M., Burmeister, B. H., Smithers, B. M., Zalcberg, J. R., Simes, R. J., Barbour, A., et al. (2011). Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: An updated meta-analysis. The Lancet Oncology, 12(7), 681–692.PubMedCrossRef Sjoquist, K. M., Burmeister, B. H., Smithers, B. M., Zalcberg, J. R., Simes, R. J., Barbour, A., et al. (2011). Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: An updated meta-analysis. The Lancet Oncology, 12(7), 681–692.PubMedCrossRef
40.
go back to reference Fedeli, U., Schievano, E., & Lisiero, M. (2012). Mortality after esophageal and gastric cancer resection. World Journal of Surgery, 36(11), 2630–2636.PubMedCrossRef Fedeli, U., Schievano, E., & Lisiero, M. (2012). Mortality after esophageal and gastric cancer resection. World Journal of Surgery, 36(11), 2630–2636.PubMedCrossRef
41.
go back to reference Biere, S. S., Maas, K. W., Bonavina, L., Garcia, J. R., van Berge Henegouwen, M. I., Rosman, C., et al. (2011). Traditional invasive versus minimally invasive esophagectomy: A multi-center, randomized trial (TIME-trial). British Medical Journal Surgery, 11, 2. Biere, S. S., Maas, K. W., Bonavina, L., Garcia, J. R., van Berge Henegouwen, M. I., Rosman, C., et al. (2011). Traditional invasive versus minimally invasive esophagectomy: A multi-center, randomized trial (TIME-trial). British Medical Journal Surgery, 11, 2.
42.
go back to reference Shah, R., & Jobe, B. A. (2011). Open versus minimally invasive esophagectomy: What is the best approach? Minimally invasive esophagectomy. Journal of Gastrointestinal Surgery, 15(9), 1503–1505.PubMedCrossRef Shah, R., & Jobe, B. A. (2011). Open versus minimally invasive esophagectomy: What is the best approach? Minimally invasive esophagectomy. Journal of Gastrointestinal Surgery, 15(9), 1503–1505.PubMedCrossRef
43.
go back to reference Duval, S., & Tweedie, R. (2000). Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics, 56(2), 455–463.PubMedCrossRef Duval, S., & Tweedie, R. (2000). Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics, 56(2), 455–463.PubMedCrossRef
44.
go back to reference Rosenthal, R. (1979). The ‘file drawer problem’ and tolerance for null results. Psychological Bulletin, 86, 638–641.CrossRef Rosenthal, R. (1979). The ‘file drawer problem’ and tolerance for null results. Psychological Bulletin, 86, 638–641.CrossRef
45.
go back to reference Egger, M., Davey, S. G., Schneider, M., & Minder, C. (1997). Bias in meta-analysis detected by a simple, graphical test. British Medical Journal, 315(7109), 629–634.PubMedCentralPubMedCrossRef Egger, M., Davey, S. G., Schneider, M., & Minder, C. (1997). Bias in meta-analysis detected by a simple, graphical test. British Medical Journal, 315(7109), 629–634.PubMedCentralPubMedCrossRef
46.
go back to reference Teoh, A. Y., Yan Chiu, P. W., Wong, T. C., Liu, S. Y., Hung Wong, S. K., & Ng, E. K. (2011). Functional performance and quality of life in patients with squamous esophageal carcinoma receiving surgery or chemoradiation: Results from a randomized trial. Annals of Surgery, 253(1), 1–5.PubMedCrossRef Teoh, A. Y., Yan Chiu, P. W., Wong, T. C., Liu, S. Y., Hung Wong, S. K., & Ng, E. K. (2011). Functional performance and quality of life in patients with squamous esophageal carcinoma receiving surgery or chemoradiation: Results from a randomized trial. Annals of Surgery, 253(1), 1–5.PubMedCrossRef
47.
go back to reference Nafteux, P., Moons, J., Coosemans, W., Decaluwe, H., Decker, G., De, L. P., et al. (2011). Minimally invasive oesophagectomy: A valuable alternative to open oesophagectomy for the treatment of early oesophageal and gastro-oesophageal junction carcinoma. European Journal of Cardio-Thoracic Surgery, 40(6), 1455–1463.PubMed Nafteux, P., Moons, J., Coosemans, W., Decaluwe, H., Decker, G., De, L. P., et al. (2011). Minimally invasive oesophagectomy: A valuable alternative to open oesophagectomy for the treatment of early oesophageal and gastro-oesophageal junction carcinoma. European Journal of Cardio-Thoracic Surgery, 40(6), 1455–1463.PubMed
48.
go back to reference Parameswaran, R., Blazeby, J. M., Hughes, R., Mitchell, K., Berrisford, R. G., & Wajed, S. A. (2010). Health-related quality of life after minimally invasive oesophagectomy. British Journal of Surgery, 97(4), 525–531.PubMedCrossRef Parameswaran, R., Blazeby, J. M., Hughes, R., Mitchell, K., Berrisford, R. G., & Wajed, S. A. (2010). Health-related quality of life after minimally invasive oesophagectomy. British Journal of Surgery, 97(4), 525–531.PubMedCrossRef
49.
go back to reference Wang, H., Tan, L., Feng, M., Zhang, Y., & Wang, Q. (2011). Comparison of the short-term health-related quality of life in patients with esophageal cancer with different routes of gastric tube reconstruction after minimally invasive esophagectomy. Quality of Life Research, 20(2), 179–189.PubMedCrossRef Wang, H., Tan, L., Feng, M., Zhang, Y., & Wang, Q. (2011). Comparison of the short-term health-related quality of life in patients with esophageal cancer with different routes of gastric tube reconstruction after minimally invasive esophagectomy. Quality of Life Research, 20(2), 179–189.PubMedCrossRef
50.
go back to reference Wang, H., Feng, M., Tan, L., & Wang, Q. (2010). Comparison of the short-term quality of life in patients with esophageal cancer after subtotal esophagectomy via video-assisted thoracoscopic or open surgery. Diseases of the Esophagus, 23(5), 408–414.PubMed Wang, H., Feng, M., Tan, L., & Wang, Q. (2010). Comparison of the short-term quality of life in patients with esophageal cancer after subtotal esophagectomy via video-assisted thoracoscopic or open surgery. Diseases of the Esophagus, 23(5), 408–414.PubMed
51.
go back to reference Safieddine, N., Xu, W., Quadri, S. M., Knox, J. J., Hornby, J., Sulman, J., et al. (2009). Health-related quality of life in esophageal cancer: Effect of neoadjuvant chemoradiotherapy followed by surgical intervention. Journal of Thoracic and Cardiovascular Surgery, 137(1), 36–42.PubMedCrossRef Safieddine, N., Xu, W., Quadri, S. M., Knox, J. J., Hornby, J., Sulman, J., et al. (2009). Health-related quality of life in esophageal cancer: Effect of neoadjuvant chemoradiotherapy followed by surgical intervention. Journal of Thoracic and Cardiovascular Surgery, 137(1), 36–42.PubMedCrossRef
52.
go back to reference van Meerten, E., van der Gaast, A., Looman, C. W., Tilanus, H. W., Muller, K., & Essink-Bot, M. L. (2008). Quality of life during neoadjuvant treatment and after surgery for resectable esophageal carcinoma. International Journal of Radiation Oncology Biology Physics, 71(1), 160–166.CrossRef van Meerten, E., van der Gaast, A., Looman, C. W., Tilanus, H. W., Muller, K., & Essink-Bot, M. L. (2008). Quality of life during neoadjuvant treatment and after surgery for resectable esophageal carcinoma. International Journal of Radiation Oncology Biology Physics, 71(1), 160–166.CrossRef
53.
go back to reference Barbour, A. P., Lagergren, P., Hughes, R., Alderson, D., Barham, C. P., & Blazeby, J. M. (2008). Health-related quality of life among patients with adenocarcinoma of the gastro-oesophageal junction treated by gastrectomy or oesophagectomy. British Journal of Surgery, 95(1), 80–84.PubMedCrossRef Barbour, A. P., Lagergren, P., Hughes, R., Alderson, D., Barham, C. P., & Blazeby, J. M. (2008). Health-related quality of life among patients with adenocarcinoma of the gastro-oesophageal junction treated by gastrectomy or oesophagectomy. British Journal of Surgery, 95(1), 80–84.PubMedCrossRef
54.
go back to reference Lagergren, P., Avery, K. N. L., Hughes, R., Barham, C. P., Alderson, D., Falk, S. J. et al. Health-related quality of life among patients cured by surgery for esophageal cancer. Cancer, 110(3), 686–693. Lagergren, P., Avery, K. N. L., Hughes, R., Barham, C. P., Alderson, D., Falk, S. J. et al. Health-related quality of life among patients cured by surgery for esophageal cancer. Cancer, 110(3), 686–693.
55.
go back to reference Tan, Q. Y., Wang, R. W., Jiang, Y. G., Fan, S. Z., Hsin, M. K., Gong, T. Q., et al. (2006). Lung volume reduction surgery allows esophageal tumor resection in selected esophageal carcinoma with severe emphysema. Annals of Thoracic Surgery, 82(5), 1849–1856.PubMedCrossRef Tan, Q. Y., Wang, R. W., Jiang, Y. G., Fan, S. Z., Hsin, M. K., Gong, T. Q., et al. (2006). Lung volume reduction surgery allows esophageal tumor resection in selected esophageal carcinoma with severe emphysema. Annals of Thoracic Surgery, 82(5), 1849–1856.PubMedCrossRef
56.
go back to reference Reynolds, J. V., McLaughlin, R., Moore, J., Rowley, S., Ravi, N., & Byrne, P. J. (2006). Prospective evaluation of quality of life in patients with localized oesophageal cancer treated by multimodality therapy or surgery alone. British Journal of Surgery, 93(9), 1084–1090.PubMedCrossRef Reynolds, J. V., McLaughlin, R., Moore, J., Rowley, S., Ravi, N., & Byrne, P. J. (2006). Prospective evaluation of quality of life in patients with localized oesophageal cancer treated by multimodality therapy or surgery alone. British Journal of Surgery, 93(9), 1084–1090.PubMedCrossRef
57.
go back to reference de Boer, A. G., van Lanschot, J. J., van Sandick, J. W., Hulscher, J. B., Stalmeier, P. F., de Haes, J. C., et al. (2004). Quality of life after transhiatal compared with extended transthoracic resection for adenocarcinoma of the esophagus. Journal of Clinical Oncology, 22(20), 4202–4208.PubMedCrossRef de Boer, A. G., van Lanschot, J. J., van Sandick, J. W., Hulscher, J. B., Stalmeier, P. F., de Haes, J. C., et al. (2004). Quality of life after transhiatal compared with extended transthoracic resection for adenocarcinoma of the esophagus. Journal of Clinical Oncology, 22(20), 4202–4208.PubMedCrossRef
58.
go back to reference Brooks, J. A., Kesler, K. A., Johnson, C. S., Ciaccia, D., & Brown, J. W. (2002). Prospective analysis of quality of life after surgical resection for esophageal cancer: Preliminary results. Journal of Surgical Oncology, 81(4), 185–194.PubMedCrossRef Brooks, J. A., Kesler, K. A., Johnson, C. S., Ciaccia, D., & Brown, J. W. (2002). Prospective analysis of quality of life after surgical resection for esophageal cancer: Preliminary results. Journal of Surgical Oncology, 81(4), 185–194.PubMedCrossRef
59.
go back to reference Scarpa, M., Saadeh, L. M., Fasolo, A., Alfieri, R., Cagol, M., Cavallin, F., et al. (2013). Health-related quality of life in patients with oesophageal cancer: Analysis at different steps of the treatment pathway. Journal of Gastrointestinal Surgery,. doi:10.1007/s11605-012-2069-1. Scarpa, M., Saadeh, L. M., Fasolo, A., Alfieri, R., Cagol, M., Cavallin, F., et al. (2013). Health-related quality of life in patients with oesophageal cancer: Analysis at different steps of the treatment pathway. Journal of Gastrointestinal Surgery,. doi:10.​1007/​s11605-012-2069-1.
60.
go back to reference Biere, S. S., van Berge Henegouwen, M. I., Maas, K. W., Bonavina, L., Rosman, C., Garcia, J. R., et al. (2012). Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: A multicentre, open-label, randomised controlled trial. Lancet, 379(9829), 1887–1892.PubMedCrossRef Biere, S. S., van Berge Henegouwen, M. I., Maas, K. W., Bonavina, L., Rosman, C., Garcia, J. R., et al. (2012). Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: A multicentre, open-label, randomised controlled trial. Lancet, 379(9829), 1887–1892.PubMedCrossRef
61.
go back to reference Briez, N., Piessen, G., Bonnetain, F., Brigand, C., Carrere, N., Collet, D., et al. (2011). Open versus laparoscopically-assisted oesophagectomy for cancer: A multicentre randomised controlled phase III trial—the MIRO trial. BMC Cancer, 11(310), 310.PubMedCentralPubMedCrossRef Briez, N., Piessen, G., Bonnetain, F., Brigand, C., Carrere, N., Collet, D., et al. (2011). Open versus laparoscopically-assisted oesophagectomy for cancer: A multicentre randomised controlled phase III trial—the MIRO trial. BMC Cancer, 11(310), 310.PubMedCentralPubMedCrossRef
62.
go back to reference Zhang, C., Wu, Q. C., Hou, P. Y., Zhang, M., Li, Q., Jiang, Y. J., et al. (2011). Impact of the method of reconstruction after oncologic oesophagectomy on quality of life—a prospective, randomised study. European Journal of Cardio-Thoracic Surgery, 39(1), 109–114.PubMedCrossRef Zhang, C., Wu, Q. C., Hou, P. Y., Zhang, M., Li, Q., Jiang, Y. J., et al. (2011). Impact of the method of reconstruction after oncologic oesophagectomy on quality of life—a prospective, randomised study. European Journal of Cardio-Thoracic Surgery, 39(1), 109–114.PubMedCrossRef
63.
64.
go back to reference Derogar, M., Orsini, N., Sadr-Azodi, O., & Lagergren, P. (2012). Influence of major postoperative complications on health-related quality of life among long-term survivors of esophageal cancer surgery. Journal of Clinical Oncology, 30(14), 1615–1619.PubMedCrossRef Derogar, M., Orsini, N., Sadr-Azodi, O., & Lagergren, P. (2012). Influence of major postoperative complications on health-related quality of life among long-term survivors of esophageal cancer surgery. Journal of Clinical Oncology, 30(14), 1615–1619.PubMedCrossRef
65.
go back to reference Sprangers, M. A., Sloan, J. A., Barsevick, A., Chauhan, C., Dueck, A. C., Raat, H., et al. (2010). Scientific imperatives, clinical implications, and theoretical underpinnings for the investigation of the relationship between genetic variables and patient-reported quality-of-life outcomes. Quality of Life Research, 19(10), 1395–1403.PubMedCentralPubMedCrossRef Sprangers, M. A., Sloan, J. A., Barsevick, A., Chauhan, C., Dueck, A. C., Raat, H., et al. (2010). Scientific imperatives, clinical implications, and theoretical underpinnings for the investigation of the relationship between genetic variables and patient-reported quality-of-life outcomes. Quality of Life Research, 19(10), 1395–1403.PubMedCentralPubMedCrossRef
66.
67.
go back to reference Wood, L., Egger, M., Gluud, L. L., Schulz, K. F., Juni, P., Altman, D. G., et al. (2008). Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: Meta-epidemiological study. British Medical Journal, 336(7644), 601–605.PubMedCentralPubMedCrossRef Wood, L., Egger, M., Gluud, L. L., Schulz, K. F., Juni, P., Altman, D. G., et al. (2008). Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: Meta-epidemiological study. British Medical Journal, 336(7644), 601–605.PubMedCentralPubMedCrossRef
68.
go back to reference Moher, D., Pham, B., Lawson, M. L., & Klassen, T. P. (2003). The inclusion of reports of randomised trials published in languages other than English in systematic reviews. Health Technology Assessment, 7(41), 1–90.PubMed Moher, D., Pham, B., Lawson, M. L., & Klassen, T. P. (2003). The inclusion of reports of randomised trials published in languages other than English in systematic reviews. Health Technology Assessment, 7(41), 1–90.PubMed
Metagegevens
Titel
Meta-analysis shows clinically relevant and long-lasting deterioration in health-related quality of life after esophageal cancer surgery
Auteurs
M. Jacobs
R. C. Macefield
R. G. Elbers
K. Sitnikova
I. J. Korfage
E. M. A. Smets
I. Henselmans
M. I. van Berge Henegouwen
J. C. J. M. de Haes
J. M. Blazeby
M. A. G. Sprangers
Publicatiedatum
01-05-2014
Uitgeverij
Springer International Publishing
Gepubliceerd in
Quality of Life Research / Uitgave 4/2014
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-013-0545-z

Andere artikelen Uitgave 4/2014

Quality of Life Research 4/2014 Naar de uitgave